We are live on ! Find out more
CWM

CIBC World Markets Portfolio holdings

AUM $20.8B
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.1B
AUM Growth
+$3.21B
Cap. Flow
+$3.07B
Cap. Flow %
18%
Top 10 Hldgs %
37.34%
Holding
1,352
New
639
Increased
483
Reduced
198
Closed
27

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$605M
2
HON icon
Honeywell
HON
+$225M
3
MSFT icon
Microsoft
MSFT
+$211M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$154M
5
MA icon
Mastercard
MA
+$139M

Sector Composition

Rank Sector Weight
1 Technology 29.27%
2 Financials 12.16%
3 Communication Services 9.98%
4 Consumer Discretionary 8.73%
5 Healthcare 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLPX
1301
DELISTED
Olaplex Holdings
OLPX
$22.4K ﹤0.01%
+12,976
New +$25.8K
BARK icon
1302
BARK
BARK
$82.7M
$22.4K ﹤0.01%
+608
New +$21.3K
OCGN icon
1303
Ocugen
OCGN
$420M
$21.6K ﹤0.01%
+26,787
New +$24.5K
SANA icon
1304
Sana Biotechnology
SANA
$949M
$20.2K ﹤0.01%
+12,372
New +$36.9K
REI icon
1305
Ring Energy
REI
$325M
$18.9K ﹤0.01%
+13,869
New +$20.8K
PROK icon
1306
ProKidney
PROK
$337M
$17.3K ﹤0.01%
+10,261
New +$18.5K
HRTX icon
1307
Heron Therapeutics
HRTX
$94.5M
$16.8K ﹤0.01%
+10,986
New +$17.8K
NKTR icon
1308
Nektar Therapeutics
NKTR
$2.48B
$15.5K ﹤0.01%
+1,114
New +$19.6K
MRSN
1309
DELISTED
Mersana Therapeutics
MRSN
$15.2K ﹤0.01%
+425
New +$22K
IAUX
1310
i-80 Gold Corp
IAUX
$1.31B
$14.4K ﹤0.01%
+29,631
New +$24K
CHRS icon
1311
Coherus Oncology
CHRS
$194M
$14.4K ﹤0.01%
+10,412
New +$11.7K
LNZA icon
1312
LanzaTech
LNZA
$68M
$14.3K ﹤0.01%
+105
New +$15.8K
PGEN icon
1313
Precigen
PGEN
$2.47B
$14.1K ﹤0.01%
+12,610
New +$10.8K
GPRO icon
1314
GoPro
GPRO
$126M
$12.8K ﹤0.01%
+11,712
New +$14.9K
XFOR icon
1315
X4 Pharmaceuticals
XFOR
$393M
$11.5K ﹤0.01%
+524
New +$8.35K
ATOS icon
1316
Atossa Therapeutics
ATOS
$24.1M
$11.2K ﹤0.01%
+789
New +$15.4K
FRGE
1317
DELISTED
Forge Global Holdings
FRGE
$10.1K ﹤0.01%
+727
New +$12K
LYEL icon
1318
Lyell Immunopharma
LYEL
$348M
$9.63K ﹤0.01%
+752
New +$14.9K
LNAI
1319
Lunai Bioworks
LNAI
$11M
$9.04K ﹤0.01%
+135
New +$8.96K
STEM icon
1320
Stem
STEM
$51.5M
$8.57K ﹤0.01%
+710
New +$6.11K
VERU icon
1321
Veru
VERU
$37.1M
$8.04K ﹤0.01%
+1,236
New +$9.17K
LXRX icon
1322
Lexicon Pharmaceuticals
LXRX
$1.05B
$7.93K ﹤0.01%
+10,744
New +$13K
LCTX icon
1323
Lineage Cell Therapeutics
LCTX
$282M
$6.95K ﹤0.01%
+13,825
New +$10.2K
SAVE
1324
DELISTED
Spirit Airlines, Inc.
SAVE
$3.51K ﹤0.01%
+10,478
New +$22.8K
AGI icon
1325
Alamos Gold
AGI
$13B
-27,000
Closed -$538K

Similar funds

CIBC World Markets's Q4 2024 Portfolio in Review

As of Q4 2024, CIBC World Markets held 1,352 positions worth $17.1B, up 23% from $13.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CIBC World Markets deployed $3.07B of net new capital in Q4 2024, opening 639 new positions and adding to 483 existing holdings. Its largest new stake was Apellis Pharmaceuticals: 1,285,300 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Air Products & Chemicals, an estimated $97.3M trimmed.

  • CIBC World Markets's largest Q4 2024 buy was Apellis Pharmaceuticals: 1,285,300 shares worth $41M.
  • CIBC World Markets added most to NVIDIA in Q4 2024, an estimated $605M increase.
  • CIBC World Markets's biggest Q4 2024 reduction was Air Products & Chemicals, cutting an estimated $97.3M.
  • CIBC World Markets fully exited iShares Short-Term National Muni Bond ETF in Q4 2024, selling an estimated $54.3M.
  • CIBC World Markets's ten largest holdings make up 37% of its $17.1B portfolio in Q4 2024.
  • CIBC World Markets opened 639 new positions and closed 27 in Q4 2024.
  • CIBC World Markets's portfolio value rose 23% quarter-over-quarter to $17.1B.

Based on CIBC World Markets's 13F filing for Q4 2024, filed 10 Feb 2025.